Many cultured human cell lines show large synergistic cytotoxicity when an
inhibitor of dihydrofolate reductase (EC 1.5.1.3) is combined with an antif
olate inhibitor of thymidylate synthase (EC 2.1.1.45) or with an antifolate
inhibitor of glycinamide ribonucleotide formyltransferase (EC 2.1.2.2). Th
ese synergistic interactions are dependent on medium folic acid concentrati
on and are greatly enhanced by increasing folic acid levels. Synergism is s
een only when the thymidylate synthase or glycinamide ribonucleotide formyl
transferase inhibitor is polyglutamylatable. Here we will briefly outline t
he rigorous method used to quantitate synergistic interactions by measuring
or, a response surface-based parameter; give examples of synergistic inter
actions from the current literature; and evaluate proposals offered to expl
ain the metabolic basis of the synergism. (C) 2000 Elsevier Science Inc. Al
l rights reserved.